In a finding that could help reduce the racial disparity in kidney disease, Duke Health researchers have detailed how two common gene variants among African Americans can cause kidney failure.
Feb 29, 2024
0
0
A new drug could offer a powerful way to sensitize tumors to immunotherapy, a new trial suggests. The results have been published in the Journal of Clinical Investigation.
Feb 27, 2024
0
1
When getting vaccines, switching arms for each dose may produce greater immunity than having the jabs delivered into the same arm.
Feb 6, 2024
0
26
Scientists led by a team at Duke-NUS Medical School have made a breakthrough in understanding the mechanisms that influence cancer cell growth and development. Publishing in the Journal of Clinical Investigation, the researchers ...
Feb 2, 2024
0
2
While newly approved drugs for Alzheimer's show some promise for slowing the memory-robbing disease, the current treatments fall far short of being effective at regaining memory. What is needed are more treatment options ...
Feb 1, 2024
0
123
One of the major challenges in cancer research and clinical care is understanding the molecular basis for therapeutic resistance as a major cause of long-term treatment failures. In cases of melanoma, the main targeted therapeutic ...
Feb 1, 2024
0
0
Currently used Food and Drug Administration-approved transplant drugs—with the addition of an also already FDA-approved complement inhibitor—are the optimal immunosuppression regimen for pig-to-human kidney transplants, ...
Jan 25, 2024
0
26
Childhood interstitial lung disease (chILD) is a group of rare, genetic lung disorders affecting infants and children who typically present with a range of symptoms, such as shortness of breath, rapid breathing and coughing. ...
Jan 16, 2024
0
14
Northwestern Medicine investigators have identified a previously unknown regulator of tumor immune evasion, which may help improve the efficacy of current and future anti-tumor immunotherapies, according to recent findings ...
Jan 15, 2024
0
13
Advancements in the study of two rare heart conditions—peripartum cardiomyopathy (PPCM), and dilated cardiomyopathy (DCM)—contributed by researchers at the Perelman School of Medicine at the University of Pennsylvania ...
Jan 11, 2024
0
0
